William Kirk

Sean Wong

Aaron Grey

Colin George

James Udasco

Remington Smith

- ZeroStack, a subsidiary of Flora Growth Corp., secured **over $401 million** in support, comprising digital assets, token allocations, convertible notes, and a **$13.66 million** cash raise through the sale of FLGC shares.  **[1790169_0001062993-25-016027_exhibit99-1.htm:0]** 
- The **$0G token** was launched on **September 22, 2025**, with an initial valuation of **$3.00 per token**.  **[1790169_0001062993-25-016027_exhibit99-1.htm:0]**  As of October 8, 2025, the token was trading at **$2.78**, resulting in a market capitalization of approximately **$593 million**.  **[1790169_0001062993-25-016027_exhibit99-1.htm:0]** 
- ZeroStack successfully sold **175,500 AI Alignment Node licenses**, generating **$30 million**.  **[1790169_0001062993-25-016027_exhibit99-1.htm:0]** 
- **Daniel Reis-Faria** was appointed CEO and board director, and **Michael Heinrich** was appointed Executive Chairman and board director, with **Dany Vaiman** remaining as CFO.  **[1790169_0001062993-25-016027_exhibit99-1.htm:0]**

ZeroStack, a Flora Growth Corp. subsidiary, secures over $401 million in funding and launches $0G token

- Flora Growth Corp. filed a prospectus supplement on **September 29, 2025**, to establish a new "at the market" (ATM) program.  **[1790169_0001062993-25-015845_form8k.htm:0]** 
- Under this new ATM program, the company may sell up to an additional **$3,450,000** of common shares.  **[1790169_0001062993-25-015845_form8k.htm:0]** 
- This new offering replaces a previous prospectus supplement, under which **$129,482** in common shares had been sold.  **[1790169_0001062993-25-015845_form8k.htm:0]**

Flora Growth Corp. initiates new at-the-market offering for common shares

- Flora Growth Corp. entered into an **"at-the-market" sales agreement** with Revere Securities LLC on **September 23, 2025**.  **[1790169_0001062993-25-015754_form8k.htm:1]** 
- This agreement allows the company to **sell common shares** from time to time through Revere Securities LLC, acting as the sales agent.  **[1790169_0001062993-25-015754_exhibit1-1.htm:0]** **[1790169_0001062993-25-015754_form8k.htm:1]** 
- The company intends to use the **net proceeds for general corporate purposes**.  **[1790169_0001062993-25-015754_form8k.htm:1]** **[1790169_0001062993-25-015754_exhibit1-1.htm:26]** 
- The compensation payable to the agent is tiered: **3.00%** for the first $150 million, **2.00%** for the next $350 million, and **1.25%** for proceeds exceeding $500 million.  **[1790169_0001062993-25-015754_form8k.htm:1]** **[1790169_0001062993-25-015754_exhibit1-1.htm:45]** 
- Flora Growth Corp. is **not obligated to make any sales** under this agreement.  **[1790169_0001062993-25-015754_form8k.htm:1]**

Flora Growth Corp. Enters At-The-Market Sales Agreement

- Flora Growth Corp. has released unaudited pro forma consolidated financial statements as of June 30, 2025, and for the six months ended June 30, 2025, and the year ended December 31, 2024, reflecting the **disposition of its hemp and cannabis-related businesses**.  **[1790169_0001062993-25-015748_exhibit99-1.htm:0]** **[1790169_0001062993-25-015748_exhibit99-1.htm:1]** **[1790169_0001062993-25-015748_exhibit99-1.htm:2]** **[1790169_0001062993-25-015748_form8k.htm:13]** 
- The pro forma net loss for the six months ended June 30, 2025, is **$(3,257) thousand**, and for the year ended December 31, 2024, is **$(8,985) thousand**.  **[1790169_0001062993-25-015748_exhibit99-1.htm:1]** **[1790169_0001062993-25-015748_exhibit99-1.htm:2]** 
- As of June 30, 2025, the company's pro forma total assets are **$7,861 thousand**, with total shareholders' equity at **$(644) thousand**.  **[1790169_0001062993-25-015748_exhibit99-1.htm:0]** 
- On September 19, 2025, Flora Growth Corp. entered into a Securities Purchase Agreement to sell Common Shares and Warrants to investors, with shares priced at **US$25.19** and prefunded warrants at **US$25.1899**.  **[1790169_0001062993-25-015748_exhibit10-1.htm:0]** **[1790169_0001062993-25-015748_exhibit10-2.htm:0]** 
- A Voting Agreement was also executed, requiring shareholder approval for the issuance of these securities, a potential company name change, and a stock split.  **[1790169_0001062993-25-015748_exhibit10-4.htm:56]** **[1790169_0001062993-25-015748_exhibit10-2.htm:63]**

Flora Growth (FLGC)